Search research articles
Contact Us
Filters
Showing results (901-910 of 920) with videos related to
Page
of 92
Sort By:
NPJ Genomic Medicine
|
May 9, 2025
Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing
Alexandra C Keefe, Dana M Jensen, Meranda M Pham, et al.
Journal of the American Society for Mass Spectrometry
|
October 21, 2017
Proof of Concept Coded Aperture Miniature Mass Spectrometer Using a Cycloidal Sector Mass Analyzer, a Carbon Nanotube (CNT) Field Emission Electron Ionization Source, and an Array Detector
Jason J Amsden, Philip J Herr, David M W Landry, et al.
Pathogens and Disease
|
May 31, 2018
Mycobacterial biomaterials and resources for researchers
Manzour Hernando Hazbón, Leen Rigouts, Marco Schito, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 18, 2024
Genetic variants in <i>DDX53</i> contribute to Autism Spectrum Disorder associated with the Xp22.11 locus
Marcello Scala, Clarrisa A Bradley, Jennifer L Howe, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 29, 2020
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
Kun Han, Robert V Blair, Naoki Iwanaga, et al.
Diabetes
|
April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Michael J Haller, S Alice Long, J Lori Blanchfield, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
Mark R Rigby, Linda A DiMeglio, Marc S Rendell, et al.
Diabetes Care
|
March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
William E Russell, Brian N Bundy, Mark S Anderson, et al.
HGG Advances
|
August 30, 2024
Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function
Giovanna Carpentieri, Serena Cecchetti, Gianfranco Bocchinfuso, et al.
American Journal of Human Genetics
|
December 20, 2024
Genetic variants in DDX53 contribute to autism spectrum disorder associated with the Xp22.11 locus
Marcello Scala, Clarrisa A Bradley, Jennifer L Howe, et al.
Page
of 92
Search research articles
Search
Showing results (901-910 of 920) with videos related to
Sort By:
Page
of 92
NPJ Genomic Medicine
|
May 9, 2025
Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing
Alexandra C Keefe, Dana M Jensen, Meranda M Pham, et al.
Journal of the American Society for Mass Spectrometry
|
October 21, 2017
Proof of Concept Coded Aperture Miniature Mass Spectrometer Using a Cycloidal Sector Mass Analyzer, a Carbon Nanotube (CNT) Field Emission Electron Ionization Source, and an Array Detector
Jason J Amsden, Philip J Herr, David M W Landry, et al.
Pathogens and Disease
|
May 31, 2018
Mycobacterial biomaterials and resources for researchers
Manzour Hernando Hazbón, Leen Rigouts, Marco Schito, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 18, 2024
Genetic variants in <i>DDX53</i> contribute to Autism Spectrum Disorder associated with the Xp22.11 locus
Marcello Scala, Clarrisa A Bradley, Jennifer L Howe, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 29, 2020
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
Kun Han, Robert V Blair, Naoki Iwanaga, et al.
Diabetes
|
April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Michael J Haller, S Alice Long, J Lori Blanchfield, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
Mark R Rigby, Linda A DiMeglio, Marc S Rendell, et al.
Diabetes Care
|
March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
William E Russell, Brian N Bundy, Mark S Anderson, et al.
HGG Advances
|
August 30, 2024
Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function
Giovanna Carpentieri, Serena Cecchetti, Gianfranco Bocchinfuso, et al.
American Journal of Human Genetics
|
December 20, 2024
Genetic variants in DDX53 contribute to autism spectrum disorder associated with the Xp22.11 locus
Marcello Scala, Clarrisa A Bradley, Jennifer L Howe, et al.
Page
of 92